68 results about "Protocatechuic aldehyde" patented technology

The invention discloses a method for establishing an HPLC fingerprint spectrum of a Zhuang medicinal material Blumea riparia (Bl.) DC. By adopting a high-performance liquid chromatography, and using main ingredients such as protocatechuic acid and protocatechuic aldehyde of Blumea riparia (Bl.) DC as reference substances, a fingerprint spectrum of a common pattern of the Zhuang medicine Blumea riparia (Bl.) DC medicinal material is obtained. The fingerprint spectrum has 13 chromatographic peaks, can fully reflect the chemical compositions of the Blumea riparia (Bl.) DC medicinal material, and is rich in information amount, the method has good reproducibility, a more powerful theoretical basis is provided for controlling the quality of the medicinal material and identifying the advantages and disadvantages of the medicinal material, the quality control and the level of true and false identification of the Zhuang medicine Blumea riparia (Bl.) DC medicinal material are improved, and the authenticity and the advantages and disadvantages of the Blumea riparia (Bl.) DC can be quickly and accurately identified.

The invention is concerned with a kind of extract of total ketone of salviae miltiorrhizae and total phenolic acid and its produce method form radix Salviae Miltiorrhizae. The extract of total ketoneof salviae miltiorrhizae has cryptotanshinone, tanshinone I, tanshinone IIA, methyl Tanshinon, dihydrotanshinon I and ramification. The extract of total phenolic acid has salvianolic acid A, salvianolic acid B, protocatechuic aldehyde and ramification. The extract can be got form one or arbitrary compound of extraction with solvent method, macroporous resin method, column chromatography and liquid-liquid counter-current chromatography. The summation of the content to each total ketone of salviae miltiorrhizae is 20 to 100 percnte (w / w) of the extract of total ketone of salviae miltiorrhizae, the contene of cryptotanshinone, tanshinone I and tanshinone IIA is 5 to 100 percent (w / w) of whole content of total ketone of salviae miltiorrhizae. The summation of the content to each total phenolicacid is 5 to 100 percent (w / w) of the extract of the radix salviae miltiorrhizae total phenolic acid. The content of salvianolic acid B is the 5 to 100 percent (w / w) of the whole salvianolic acid.

The pharmaceutical composition for treating senile dementia relates to a medicinal product using plants as raw materials. It is an oral preparation made of medicinal active parts and conventional pharmaceutical excipients according to the conventional traditional Chinese medicine preparation process. The medicinal active parts are mainly prepared from Danshen and Panax notoginseng. Contains tanshinone II A 1.79~9.01mg, salvianolic acid B 35.87~225.23mg, danshensu 4.93~45.05mg, protocatechualdehyde 0.10~4.50mg, notoginseng saponin R13.14~22.50mg; tanshinone IIA: salvianolic acid B: The weight ratio of danshensu: protocatechualdehyde: notoginseng saponin R1 is 4-20:80-500:11-100:0.2-10:7-50. The medicament provided by the invention is effective in preventing and treating senile dementia; the active ingredient composition, content and ratio of the product are clear; the product quality is controllable and operable; and it can be mass-produced.

An extract of red sage root for preparing the injection to treat coronary heart disease and angina pectoris contains danshensu, protocathechuic aldehyde and danshinolic acid. Its preparing process and test method are also disclosed.